Transparent Machine Learning Stocks + Digital Assets Forecasts*
If you don't make over $60 your first month, get your money back.
Become a more profitable investor with our transparent AI stock forecasts.
Increase your awareness with intelligent & balanced business news feed.
Stay on top with forecast models models trained, tested, and updated every day.
The news feed designed to reduce addiction and increase your understanding.
We will never sell, rent, or give your personal information away under any circumstance.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
The blue line is Helium's historical forecast. The black line is the actual closing price. Full transparency of past predictions. Hover over points for more information. Video Tutorial.
Future Price Cone
The future price cone means the model thinks there is a 80% chance the price will land within the bounds of the cone. A blue cone is neutral, a green cone is bullish, and a red cone is bearish.
Model Correlation
Higher (closer to 1) means a more accurate model and lower (closer to -1) means a less accurate model. This is the Spearman Correlation between model predicted percent change and actual percent change calculated over the last 150 days.
Percent Correct (up or down)
This is the percent of the time our models predicted the correct direction of the price (either up or down) over the last 150 days.
Tip:
Left click and drag charts to zoom in. Right click to zoom back out.
* Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions, you should consult a financial expert before engaging in any transaction.
Helium Summary:
A study published in Nature Medicine on February 15, 2024, finds telehealth abortion care to be as safe and effective as in-person care.
This research, the largest of its kind, evaluated both synchronous and asynchronous telehealth abortion services, supporting them as viable options for patients, especially in areas with limited access to clinics or where abortion is restricted [Scientific American].
February 19, 2024
Evidence
Telehealth abortion study published in Nature Medicine shows safety and effectiveness of remote care [Scientific American].
Legal challenges to mifepristone's FDA approval and telehealth prescriptions by antiabortion advocates [Scientific American].
Perspectives
Public Health Researcher
Silpa Srinivasulu, not involved in the study, emphasizes the importance of this evidence, especially with the upcoming Supreme Court case that could affect mifepristone's FDA approval [Scientific American].
Antiabortion Advocates
They challenge the FDA's approval of mifepristone, arguing against telehealth prescriptions and seeking to restrict access to medication abortion [Scientific American].
Patients in Need
Individuals in rural areas or with limited clinic access may view telehealth abortion as a critical option for safe healthcare, emphasizing the importance of maintaining access amidst legal challenges [Scientific American].
Q&A
How does telehealth abortion work?
Patients receive medication abortion through virtual consultations, using mifepristone and misoprostol, with follow-up as needed [Scientific American]. What are the legal challenges facing telehealth abortion?
Antiabortion advocates have filed lawsuits challenging the FDA's approval of mifepristone and its telehealth prescription guidelines [Scientific American].
The sources provide a factual account of the study's findings and the legal context, aiming for neutrality.
However, the inclusion of perspectives from both public health researchers and antiabortion advocates ensures a balanced view, acknowledging the contentious nature of abortion access.
Social Media Perspectives
The online discourse around Telehealth abortion centers on safety and accessibility, echoing broader concerns regarding healthcare, technology, and policy.
Through social media posts, it's clear that advocates for Telehealth abortion emphasize its safety and effectiveness, aligning it with general calls for innovative healthcare solutions that prioritize patient security and data protection.
Opposition or skepticism isn’t directly evident in the provided social media posts, but the broader context suggests underlying debates about technology in healthcare, personal privacy, and the reliability of remote medical services.
In essence, the social media posts reflect a nuanced discussion that values safety, innovation, and the potential of Telehealth to make abortion services more accessible, against a backdrop of varying public opinion and legal landscapes.
Context
The study's significance is heightened by ongoing legal battles over abortion rights in the U.S., particularly after the Dobbs decision overturning Roe v. Wade.
Takeaway
This study underscores the potential of telehealth to safely expand access to abortion care, highlighting the importance of evidence-based healthcare policies.
Potential Outcomes
Increased adoption of telehealth abortion, especially if the Supreme Court upholds mifepristone's approval (High Probability). This outcome is contingent on legal rulings and public acceptance.
Restrictions on telehealth abortion due to legal challenges (Medium Probability). This would depend on the Supreme Court's decision and could significantly impact access to abortion care.
* Disclaimer: Nothing on this website constitutes investment advice, performance data or any recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Helium Trades is not responsible in any way for the accuracy
of any model predictions or price data. Any mention of a particular security and related prediction data is not a recommendation to buy or sell that security. Investments in securities involve the risk of loss. Past performance is no guarantee of future results. Helium Trades is not responsible for any of your investment decisions,
you should consult a financial expert before engaging in any transaction.
Ask any question about this page!
